No Result
View All Result
SUBSCRIBE | NO FEES, NO PAYWALLS
MANAGE MY SUBSCRIPTION
NEWSLETTER
Corporate Compliance Insights
  • Home
  • About
    • About CCI
    • Writing for CCI
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Explore Topics
    • See All Articles
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Well-Being at Work
    • Leadership and Career
    • Opinion
  • Vendor News
  • Career Connection
  • Events
    • Calendar
    • Submit an Event
  • Library
    • Whitepapers & Reports
    • eBooks
    • CCI Press & Compliance Bookshelf
  • Podcasts
  • Videos
  • Subscribe
  • Home
  • About
    • About CCI
    • Writing for CCI
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Explore Topics
    • See All Articles
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Well-Being at Work
    • Leadership and Career
    • Opinion
  • Vendor News
  • Career Connection
  • Events
    • Calendar
    • Submit an Event
  • Library
    • Whitepapers & Reports
    • eBooks
    • CCI Press & Compliance Bookshelf
  • Podcasts
  • Videos
  • Subscribe
No Result
View All Result
Corporate Compliance Insights
Home Featured

COVID-19: DOJ’s Aggressive Prosecution of Fraud and Pandemic-Related Crimes

The Criminal Schemes the DOJ is Targeting

by Michael Volkov
April 14, 2020
in Featured, Fraud
COVID-19: DOJ’s Aggressive Prosecution of Fraud and Pandemic-Related Crimes

Hard times bring out the best and the worst in people. It’s the worst the Department of Justice is concerned with. Michael Volkov discusses what the DOJ is doing to focus on fraudsters preying on public panic in response to the COVID-19 pandemic. 

The Justice Department has alerted U.S. attorneys’ offices, as well as federal, state and local law enforcement of many of the common fraud schemes, and the DOJ has already prosecuted individuals and businesses for selling fake cures for COVID-19 online and other forms of fraud. In addition, given the large numbers of remote employees, the DOJ has warned about phishing emails from the World Health Organization and the Centers for Disease Control and Prevention and about fraudsters seeking donations for illegitimate or nonexistent charitable organizations.

The reported schemes include:

  • Robocalls making fraudulent offers to sell respirator masks with no intent of delivery;
  • Fake COVID-19-related apps and websites that install malware or ransomware;
  • Phishing emails asking for money or presenting malware;
  • Social media scams fraudulently seeking donations or claiming to provide stimulus funds if the recipient enters his or her bank account number;
  • Sales of fake testing kits, cures, “immunity” pills and protective equipment;
  • Fraudulent offers for free COVID-19 testing in order to obtain Medicare beneficiary information that is used to submit false medical claims for unrelated, unnecessary or fictitious testing or services;
  • Prescription drug schemes involving the submission of medical claims for unnecessary anti-retroviral treatments or other drugs that are marketed as purported cures for COVID-19;
  • Robberies of patients departing from hospitals or doctor offices;
  • Threats of violence against mayors and other public officials; and
  • Threats to intentionally infect other people.

To prosecute these schemes, the DOJ listed a number of criminal statutes that prohibit individuals and businesses engaging in fraudulent or otherwise illegal schemes. In particular, the DOJ noted that these COVID-19 fraudulent schemes may violate any number of provisions in Title 18 (see, e.g., 18 U.S.C. § 1341 (mail fraud); id. § 1343 (wire fraud); id. § 1030 (computer fraud); id. § 1347 (health care fraud); id. § 1349 (conspiracy to commit fraud); id. §§ 1028-1028A (identification fraud and aggravated identity theft); id. § 1040 (fraud in connection with major disasters and emergencies); and id. § 2320 (trafficking in counterfeit goods)).

Further, the sale of fake drugs and cures may be prohibited under Title 15 (see 15 U.S.C. § 1263(a) (introduction of misbranded or banned hazardous substances into interstate commerce)), may violate the Food, Drug and Cosmetic Act (see 21 U.S.C. § 333 (introduction of misbranded or adulterated drug or device into interstate commerce)) or may violate the Consumer Product Safety Act (see 15 U.S.C. § 2068 (sale, manufacture, distribution or import of a consumer product or other product that is not in conformity with consumer-product-safety regulations)).

If fraudsters engage in malicious hoaxes, threats against specific individuals or intentional exposure and infection of others with COVID-19, such conduct may fall under a range of criminal statutes relating to COVID-19 as “biological agent” under 18 U.S.C. § 178(1) and therefore implicate terrorism-related statutes (see, e.g., id. § 175 (development/possession of a biological agent for use as a weapon); id. § 875 (threats by wire); id. § 876 (threats by mail); id. § 1038 (false information and hoaxes regarding biological weapons); id. § 2332a (use of a weapon involving a biological agent)).

Finally, the DOJ has warned against conspiracies between individuals or businesses to fix prices, rig bids or allocate markets with respect to COVID-19 materials as criminal antitrust violations (see 15 U.S.C. § I). Monopolization or anticompetitive agreements related to critical materials needed to respond to COVID-19 can be pursued civilly under the Sherman and the Clayton Antitrust Acts (see, e.g., 15 U.S.C. § I (anticompetitive agreements); id. § 2 (monopolization); and id. § 14 (exclusive dealings)). And when the United States is injured as a result of those practices, the government may bring suit to recover its damages (see id. § 15a (damages actions when the government is the victim)).


This article was republished with permission from Michael Volkov’s blog, Corruption, Crime & Compliance.


Tags: COVID-19DOJ
Previous Post

D&O Liability Insurance in a Time of Financial Uncertainty

Next Post

Revisiting Internal Controls Around Procurement During a Pandemic

Michael Volkov

Michael Volkov

Michael-Volkov-leclairryan Michael Volkov is the CEO of The Volkov Law Group LLC, where he provides compliance, internal investigation and white collar defense services.  He can be reached at mvolkov@volkovlaw.com. Michael has extensive experience representing clients on matters involving the Foreign Corrupt Practices Act, the UK Bribery Act, money laundering, Office of Foreign Asset Control (OFAC), export controls, sanctions and International Traffic in Arms, False Claims Act, Congressional investigations, online gambling and regulatory enforcement issues. Michael served for more than 17 years as a federal prosecutor in the U.S. Attorney’s Office in the District of Columbia; for five years as the Chief Crime and Terrorism Counsel for the Senate Judiciary Committee, and Chief Crime, Terrorism and Homeland Security Counsel for the Senate and House Judiciary Committees; and as a Trial Attorney in the Antitrust Division of the U.S. Department of Justice. Michael also maintains a well-known blog: Corruption Crime & Compliance, which is frequently cited by anti-corruption professionals and professionals in the compliance industry.

Related Posts

doj sign front

4 Practical Tips for Complying With Monaco Memo

by Jennifer Kennedy Park
January 25, 2023

Preparing for expectations under the Monaco memo is easier said than done, but Jennifer Kennedy Park, an expert in white-collar...

Danske Bank: Money Laundering at Its Finest

Danske Bank: Money Laundering at Its Finest

by Corporate Compliance Insights
January 23, 2023

Something rotten in Denmark: Unpack the $2B settlement Danske Bank made with the U.S. government DOJ, SEC Settlements & Fines...

Paul Weiss Antitrust 2023_f

Paul | Weiss State of U.S. Antitrust Enforcement

by Corporate Compliance Insights
January 23, 2023

2022 was an active year for antitrust enforcement; what will 2023 hold? Where Do We Stand in 2023? The State...

doj new front

DOJ Set to Deploy More Carrots in Corporate Enforcement

by Staff and Wire Reports
January 20, 2023

Companies accused of corporate crimes will have more incentives to disclose misconduct they uncover and cooperate with federal investigations, Assistant...

Next Post
e-commerce, mini cardboard boxes on computer keyboard

Revisiting Internal Controls Around Procurement During a Pandemic

Compliance Job Interview Q&A

Jump to a Topic

AML Anti-Bribery Anti-Corruption Artificial Intelligence (AI) Automation Banking Board of Directors Board Risk Oversight Business Continuity Planning California Consumer Privacy Act (CCPA) Code of Conduct Communications Management Corporate Culture COVID-19 Cryptocurrency Culture of Ethics Cybercrime Cyber Risk Data Analytics Data Breach Data Governance DOJ Download Due Diligence Enterprise Risk Management (ERM) ESG FCPA Enforcement Actions Financial Crime Financial Crimes Enforcement Network (FinCEN) GDPR HIPAA Know Your Customer (KYC) Machine Learning Monitoring RegTech Reputation Risk Risk Assessment SEC Social Media Risk Supply Chain Technology Third Party Risk Management Tone at the Top Training Whistleblowing
No Result
View All Result

Privacy Policy

Founded in 2010, CCI is the web’s premier global independent news source for compliance, ethics, risk and information security. 

Got a news tip? Get in touch. Want a weekly round-up in your inbox? Sign up for free. No subscription fees, no paywalls. 

Follow Us

Browse Topics:

  • CCI Press
  • Compliance
  • Compliance Podcasts
  • Cybersecurity
  • Data Privacy
  • eBooks Published by CCI
  • Ethics
  • FCPA
  • Featured
  • Financial Services
  • Fraud
  • Governance
  • GRC Vendor News
  • HR Compliance
  • Internal Audit
  • Leadership and Career
  • On Demand Webinars
  • Opinion
  • Resource Library
  • Risk
  • Uncategorized
  • Videos
  • Webinars
  • Well-Being
  • Whitepapers

© 2022 Corporate Compliance Insights

No Result
View All Result
  • Home
  • About
    • About CCI
    • Writing for CCI
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Explore Topics
    • See All Articles
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Well-Being at Work
    • Leadership and Career
    • Opinion
  • Vendor News
  • Career Connection
  • Events
    • Calendar
    • Submit an Event
  • Library
    • Whitepapers & Reports
    • eBooks
    • CCI Press & Compliance Bookshelf
  • Podcasts
  • Videos
  • Subscribe

© 2022 Corporate Compliance Insights

Welcome to CCI. This site uses cookies. Please click OK to accept. Privacy Policy
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT